Health condition · plain-language reference
Liver Cancer
Also called: Hepatocellular carcinoma
Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver. Risk factors for primary liver cancer include : Having hepatitis B or C Heavy alcohol use Having cirrhosis , or scarring of the liver Having hemochromatosis , an iron storage disease Obesity and diabetes Symptoms can include a lump or pain on the right side of your abdomen and yellowing of the skin. However, you may not have symptoms until the cancer is advanced. This makes it harder to treat. Doctors use tests that examine the liver and the blood to diagnose liver cancer. Treatment options include surgery, radiation, chemotherapy, or liver transplantation . NIH: National Cancer Institute
Plain-language summary from MedlinePlus (NIH/NLM) ↗. For informational purposes only — not medical advice.
Medications used for liver cancer
Drugs whose FDA labeling names this condition among its indications — informational, not a recommendation.
- BevacizumabVascular Endothelial Growth Factor Inhibitor [EPC]›
- Cabozantinib›
- Raloxifene›
- AtezolizumabProgrammed Death Receptor-1 Blocking Antibody [EPC]›
- Atezolizumab and Hyaluronidase-tqjsProgrammed Death Receptor-1 Blocking Antibody [EPC]›
- DurvalumabProgrammed Death Ligand-1 Blocker [EPC]›
- Ethiodized OilRadiographic Contrast Agent [EPC]›
- FloxuridineAntimetabolite [EPC]›
- IpilimumabCTLA-4-directed Blocking Antibody [EPC]›
- Nivolumab and Hyaluronidase-nvhyEndoglycosidase [EPC]›
- PembrolizumabProgrammed Death Receptor-1 Blocking Antibody [EPC]›
- Pembrolizumab and Berahyaluronidase Alfa-pmphEndoglycosidase [EPC]›
- Regorafenib›
- SorafenibKinase Inhibitor [EPC]›
- TremelimumabCTLA-4-directed Blocking Antibody [EPC]›
Look up another condition or ICD-10 code